Folliculitis Market Research Report - Forecast till 2027

Folliculitis Market Share, Growth And Trends Analysis By Type (Superficial Folliculitis, Deep Folliculitis, And Others), Treatment (Medication, Warm Compress, Medicated Shampoo, And Others), End User- Forecast Till 2027

ID: MRFR/Pharma/2535-HCR | February 2021 | Region: Global | 76 pages

Folliculitis Market Overview:


Folliculitis is very common health problems across the globe. About 3 million cases found per year in the US alone. Folliculitis can be noninfectious or infectious. Although, most of the cases of folliculitis are infectious. Increasing knowledge of folliculitis, rapid adoption of products, and increasing healthcare expenditure are driving this market. Emerging economies account for a major share of the  folliculitis market which is expected to grow at the CAGR of ~4.7% during the forecast period and is estimated to reach USD 561.3 million by 2023.


Study objectives of folliculitis market:



  • To provide detailed analysis of the folliculitis market structure with historical and forecast revenue for the next six years of the various segments and sub-segments.

  • To provide insights about the key drivers, restraints, opportunities and challenges affecting the growth of folliculitis market

  • To provide analysis of the market with respect to various countries in the four main geographies– the Americas, Europe, Asia-Pacific, and Middle East & Africa.

  • To provide detailed analysis of the market segmented by type, treatment, end user, and its sub-segments.

  • To provide a detailed analysis of folliculitis market mainly based on Value Chain analysis, Porter’s Five Forces, Price analysis, and Supply Chain analysis etc.

  • To provide a detailed country level analysis of the market with respect to the current market size and future prospects.

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the folliculitis market.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the folliculitis market.


FIGURE 1                   GLOBAL FOLLICULITIS MARKET SHARE BY END USER, 2016 (%) FOLLICULITIS MARKET SHARE BY END USER, 2016


Sources: American Academy of Ophthalmology, American Academy of Allergy, Asthma & Immunology, American College of Allergy, Asthma & Immunology, National Center for Biotechnology Information, Directorate of Industries, Annual report, White paper, Company Presentation


Intended Audience:



  • Folliculitis medicines manufacturers

  • Folliculitis medicine and treatment providers

  • Hospitals and clinics

  • Medical Research laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


Research Methodology: Research Methodology folliculitis market


 Sources: American Academy of Ophthalmology, American Academy of Allergy, Asthma & Immunology, American College of Allergy, Asthma & Immunology, National Center for Biotechnology Information, Directorate of Industries, Annual report, White paper, Company Presentation


 


Segments:     


Folliculitis market has been segmented on the basis of type which comprise superficial folliculitis, deep folliculitis, and others. Superficial folliculitis is sub-segmented into bacterial folliculitis, hot tub folliculitis (pseudomonas folliculitis), barber's itch (pseudofolliculitis barbae), pityrosporum folliculitis. Deep folliculitis is sub-segmented into sycosis barbae, gram-negative folliculitis, boils (furuncles) and carbuncles, eosinophilic folliculitis.


On the basis of treatments, the market has been segmented into medication, warm compress, medicated shampoo, and others. Medication is sub-segmented into antibiotics, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), antifungals, antivirals, and others.


On the basis of end user, it is segmented into hospitals and clinics, medical research centers, academic institutes, and others.


Regional analysis of global folliculitis market:                


Considering the global scenario of the market, the Americas is holding largest market share. Some major factors are driving the growth in America such as large amount of money invested in R&D, and clinical trials. European market is second largest and countries like Germany and UK are holding largest market share. Increasing healthcare spending is major factor for Asia Pacific folliculitis market. While due to lack of knowledge of the disease and limited access to the healthcare facilities, Middle East and Africa is growing slower than the global average.


Key players for global folliculitis market:                                                     


Some of the key players in this market are: AbbVie Inc. (US), Allergan (Republic of Ireland), AstraZeneca (UK), CELGENE CORPORATION (US), GlaxoSmithKline plc. (UK), Johnson & Johnson Services, Inc. (US), Merck & Co., Inc. (US), Pfizer Inc.(US), and others. The report for Global Folliculitis Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2023: USD 561.3 Million
  • 2027: Significant Value
  •   CAGR   4.7% (2017-2023)
      Base Year   2019
      Forecast Period   2020-2027
      Historical Data   2018
      Forecast Units   Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Type, Treatment, End User
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   AbbVie Inc. (US), Allergan (Republic of Ireland), AstraZeneca (UK), CELGENE CORPORATION (US), GlaxoSmithKline plc. (UK), Johnson & Johnson Services, Inc. (US), Merck & Co., Inc. (US), Pfizer Inc.(US), and others
      Key Market Opportunities   New product launches and R&D Amongst major key Players
      Key Market Drivers

  • Increasing knowledge of folliculitis
  • Rapid adoption of products
  • Increasing healthcare expenditure


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    The folliculitis market CAGR would be 4.7% during the forecast period.

    The folliculitis market valuation would be USD 561.3 million by 2023.

    North America would dominate the folliculitis market.

    The UK and Germany would dominate the folliculitis market.

    The folliculitis market players are Allergan (Republic of Ireland), AbbVie Inc. (US), CELGENE CORPORATION (US), AstraZeneca (UK), Merck & Co., Inc. (US), Pfizer Inc.(US), Johnson & Johnson Services, Inc. (US), GlaxoSmithKline plc. (UK), and others.

    Table of Content

    1. Report Prologue

    2. Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    2.3 Market Structure

    2.4. Market Segmentation

    3. Research Methodology

    3.1 Research Process

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    3.5 Forecast Model

    4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Mega Trends

    4.5 Macroeconomic Indicators

    5. Market Factor analysis

    5.1 Value Chain Analysis

    5.2 Porters Five Forces

    5.3 Demand & Supply: Gap Analysis

    5.4 Pricing Analysis

    5.5 Investment Opportunity Analysis

    5.6 Merger and Acquisition Landscape

    5.7 Upcoming trends

    5.7.1 Market trends

    5.7.2 Technological trends

    5.7.3 Insurance & Regulations

    5.7.4 Others

    6. Global Folliculitis Market By Type

    6.1 Superficial folliculitis

    6.1.1 Bacterial folliculitis,

    6.1.2 Hot tub folliculitis (pseudomonas folliculitis),

    6.1.3 Barber's itch (pseudofolliculitis barbae),

    6.1.4 Pityrosporum folliculitis

    6.1.5 Others

    6.2 Deep folliculitis

    6.2.1 Sycosis barbae

    6.2.2 Gram-negative folliculitis

    6.2.3 Boils (furuncles) and carbuncles

    6.2.4 Eosinophilic folliculitis

    6.2.5 Others

    6.3 Others

    7. Global Folliculitis Market By Treatment

    7.1 Medication

    7.1.1 Antibiotics

    7.1.2 Nonsteroidal Anti-Inflammatory drugs (NSAIDs)

    7.1.3 Antifungals

    7.1.4 Antivirals

    7.1.5 Others

    7.2 Others


    8. Global Folliculitis Market By End User

    8.1 Hospitals and clinics

    8.2 Medical research centers

    8.3 Academic institutes

    8.4 Others

    9. Global Folliculitis Market By Region

    9.1 Introduction

    9.2 Americas

    9.2.1 North America

    9.2.1.1 The US

    9.2.1.2 Canada

    9.2.2 South America

    9.3 Europe

    9.3.1 Western Europe

    9.3.1.1 Germany

    9.3.1.2 France

    9.3.1.3 Italy

    9.3.1.4 Spain

    9.3.1.5 UK

    9.3.1.6 Rest of Western Europe

    9.3.2 Eastern Europe

    9.4 Asia

    9.4.1 China

    9.4.2 India

    9.4.3 Japan

    9.4.4 South Korea

    9.4.5 Rest of Asia

    9.5 Pacific

    9.6 Middle East and Africa

    9.6.1 UAE

    9.6.2 Saudi Arabia

    9.6.3 Egypt

    9.6.4 Rest of Middle East and Africa

    10. Competitive Landscape

    11. Company Profile

    12. Conclusion

    12.1 Key findings

    13.1.1 From CEO’s viewpoint

    13.1.2 Unmet needs of the market

    12.2 Key companies to watch

    12.3 Prediction of Folliculitis market

    13. Appendix